Overview

CD-NP in Subjects With Stable Chronic Heart Failure

Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
This human physiologic study will evaluate the effects of a new drug called CD-NP in individuals with stable chronic heart failure, with a focus on evaluating responses of the kidneys and the hormonal system.
Phase:
Phase 1
Details
Lead Sponsor:
Mayo Clinic